Back to IMVT

ARMISTICE CAPITAL, LLC → IMVT

ARMISTICE CAPITAL, LLC IMVT Position History

Immunovant, Inc. • Healthcare

Quarters held
16
Latest value
$5.1M
Q3 2026
Peak value
$146.1M
First seen
Q3 2025

Dollar value over time

Show data table
PeriodPosition value
Q3 2025$94.1M
Q4 2025$146.1M
Q4 2025$12.7M
Q4 2025$6.4M
Q1 2026$88.6M
Q1 2026$9.9M
Q1 2026$17.4M
Q1 2026$19.9M
Q2 2026$66.9M
Q2 2026$15.4M
Q2 2026$15.4M
Q2 2026$15.4M
Q3 2026$58.7M
Q3 2026$29.6M
Q3 2026$20.3M
Q3 2026$5.1M

Quarter-by-quarter history

Every disclosed snapshot of the position

QuarterValueShares% PortfolioChange
Q3 2026$5.1M150.0K——
Q3 2026$20.3M600.0K——
Q3 2026$29.6M875.0K——
Q3 2026$58.7M1.74M——
Q2 2026$15.4M400.0K——
Q2 2026$15.4M400.0K——
Q2 2026$15.4M400.0K——
Q2 2026$66.9M1.74M——
Q1 2026$19.9M800.0K——
Q1 2026$17.4M700.0K——
Q1 2026$9.9M400.0K——
Q1 2026$88.6M3.56M——
Q4 2025$6.4M250.0K——
Q4 2025$12.7M500.0K——
Q4 2025$146.1M5.75M——
Q3 2025$94.1M5.84M——

Other funds holding IMVT

Other ARMISTICE CAPITAL, LLC positions

PTCT

PTC THERAPEUTICS INC

$212.8M
PTCT

PTC THERAPEUTICS ORD

$201.1M
TVTX

TRAVERE THERAPEUTICS ORD

$160.7M
TVTX

TRAVERE THERAPEUTICS INC

$145.5M
TVTX

TRAVERE THERAPEUTICS INC

$143.8M
PTCT

PTC THERAPEUTICS INC

$141.3M
SUPN

SUPERNUS PHARMACEUTICALS INC

$137.4M
SUPN

SUPERNUS PHARMACEUTICALS ORD

$135.5M